National Institutes of Health

Description

Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), seeks research project grant (R01) applications from established, not-for-profit product development Public-Private Partnerships (PD PPPs) in order to accelerate preclinical research and development of promising preventive, therapeutic, or diagnostic tools, or vector management strategies for neglected infectious diseases. PD PPPs should have a track record of development of interventions for neglected infectious diseases of global importance, and highest prevalence in low income countries for which commercial markets provide insufficient incentives for product development. These diseases include malaria, tuberculosis, Neglected Tropical Diseases (see the following link for a list of NTDs: http://www3.niaid.nih.gov/topics/tropicalDiseases/research/examples.htm), and, where relevant, their vectors. Projects must include milestones and timelines to support projects on various aspects of preclinical development and IND enabling studies (e.g. validation of targets for intervention, process development, formulation, toxicology etc.) as well as a product development plan. Mechanism of Support. This FOA will utilize the R01 grant mechanism. Funds Available and Anticipated Number of Awards. NIAID expects to award $3.7 million in total costs in response to this FOA in FY 2010; the anticipated number of awards is 5-8.

Who can apply

• Public and State controlled institutions of higher education
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV